Skip to content

Jeffrey T. Swail, M. D.

NPI 1245312982ActiveIndividual· Plastic Surgery· Boulder, CO

Plastic Surgery (M. D.) in Boulder, Colorado, licensed in CO, with an NPI issued in October 2006. Part D covered 21 prescriptions written in 2024, 95% of them generic. Revance Therapeutics, Inc. reported $71.43 in payments in 2025, mostly food and beverage.

Overview

NPI1245312982
StatusActive
Entity typeIndividual
CredentialM. D.
Sole proprietorYes
NPI issuedOct 20, 2006
Last updated in NPPESJul 22, 2014

Specialties and licenses

TaxonomyCodeLicenseState
Plastic Surgery Primary208200000X34276CO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Plastic and Reconstructive Surgery (CO)

Part D prescriptions in 2024

Prescriptions (claims)21 · 21 30-day fills
Patients13
Total drug cost$253.55
Generic share95% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$71.43 · 1 payment from 1 company
  • 2024$79.96 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Revance Therapeutics, Inc.$71.431

What the 2025 payments were for

  • Food and Beverage$71.43 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Plastic Surgery providers in Boulder

All Plastic Surgery providers in Colorado →